High serum levels of growth hormone (gh) and insulin-like growth factor-i (igf-i) during high-dose gh treatment in short children born small for gestational age

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 4, 2006, Pages 1396-1396

  Van Dijk, Marije ^a   Mulder, Paul ^b   Houdijk, Mieke ^c   Mulder, Jaap ^d   Noordam, Kees ^e   Odink, Roelof J ^f   Rongen Westerlaken, Ciska ^g   Voorhoeve, Paul ^h   Waelkens, Johan ⁱ   Stokvis Brantsma, Jet ^j   Hokken Koelega, Anita ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c JULIANA CHILDREN S HOSPITAL   (Netherlands)

^d RIJNSTATE HOSPITAL   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF GRONINGEN   (Netherlands)

^g CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^h VU UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ CATHARINA HOSPITAL   (Netherlands)

^j LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

AREA UNDER THE CURVE; ARTICLE; BLOOD; BODY HEIGHT; CHILD; DRUG EFFECT; FEMALE; GROWTH; HUMAN; MALE; METABOLISM; NEWBORN; PHYSIOLOGY; SMALL FOR DATE INFANT;

AREA UNDER CURVE; BODY HEIGHT; CHILD; FEMALE; GROWTH; GROWTH HORMONE; HUMAN GROWTH HORMONE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE;

EID: 33646065046     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.91.4.9990     Document Type: Article

References (35)

1. Hokken-KoelegaAC, De RidderMA, LemmenRJ, Den HartogH, 1995Children born small for gestational age: do they catch up? Pediatr Res38:267–271
2. KarlbergJ, Albertsson-WiklandK1995Growth in full-term small-for-gestational- age infants: from birth to final height. Pediatr Res38:733–739
3. de WaalWJ, Hokken-KoelegaAC, StijnenT, De Muinck Keizer-Schrama SM, Drop SL1994 Endogenous and stimulated GH secretion, urinary GH excretion, and plasma IGF-I and IGF-II levels in prepubertal children with short stature after intrauterine growth retardation. The Dutch Working Group on Growth Hormone. Clin Endocrinol (Oxf)41:621–630
4. BoguszewskiM, JanssonC, RosbergS, Albertsson-WiklandK1996Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age. J Clin Endocrinol Metab81:3902–3908
5. de ZegherF, MaesM, GargoskySE, HeinrichsC, Du CajuMV, ThiryG, De SchepperJ, CraenM, BreysemL, LofstromA, JonssonP, BourguignonJP, MalvauxP, RosenfeldRG1996 High-dose growth hormone treatment of short children born small for gestational age. J Clin Endocrinol Metab81:1887–1892
6. SasT, de WaalW, MulderP, HoudijkM, JansenM, ReeserM, Hokken- Koelega A 1999 Growth hormone treatment in children with short stature born small for gestational age: 5-year results of a randomized, double-blind, doseresponse trial. J Clin Endocrinol Metab84:3064–3070
7. CutfieldWS, HofmanPL, VickersM, BreierB, BlumWF, RobinsonEM2002IGFs and binding proteins in short children with intrauterine growth retardation. J Clin Endocrinol Metab87:235–239
8. WoodsKA, van HelvoirtM, OngKK, MohnA, LevyJ, de ZegherF, DungerDB2002The somatotropic axis in short children born small for gestational age: relation to insulin resistance. Pediatr Res51:76–80
9. Albertsson-WiklandK1989Growth hormone secretion and growth hormone treatment in children with intrauterine growth retardation.Swedish Paediatric Study Group for Growth Hormone Treatment.Acta Paediatr Scand Suppl 349:35– 41; discussion53–54
10. BoguszewskiM, RosbergS, Albertsson-WiklandK1995Spontaneous 24- hour growth hormone profiles in prepubertal small for gestational age children. J Clin Endocrinol Metab80:2599–2606
11. Van ParerenY, MulderP, HoudijkM, JansenM, ReeserM, Hokken-KoelegaA2003Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial. J Clin Endocrinol Metab88:3584–3590
12. JorgensenJO, FlyvbjergA, LauritzenT, AlbertiKG, OrskovH, ChristiansenJS1988Dose-response studies with biosynthetic human growth hormone (GH) in GH-deficient patients. J Clin Endocrinol Metab67:36–40
13. HansenTK, GravholtCH, OrskovH, RasmussenMH, ChristiansenJS, JorgensenJO2002Dose dependency of the pharmacokinetics and acute lipolytic actions of growth hormone. J Clin Endocrinol Metab87:4691–4698
14. ShimM, CohenP1999IGFs and human cancer: implications regarding the risk of growth hormone therapy. Horm Res51(Suppl 3):42–51
15. CohenP, ClemmonsDR, RosenfeldRG2000 Does the GH-IGF axis play a role in cancer pathogenesis?Growth Horm IGF Res10:297–305
16. HankinsonSE, WillettWC, ColditzGA, HunterDJ, MichaudDS, DerooB, RosnerB, SpeizerFE, PollakM1998 Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet351:1393–1396
17. ChanJM, StampferMJ, GiovannucciE, GannPH, MaJ, WilkinsonP, HennekensCH, PollakM1998Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science279:563–566
18. MaJ, PollakMN, GiovannucciE, ChanJM, TaoY, HennekensCH, StampferMJ1999Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst91:620–625
19. Hokken-KoelegaAC, HackengWH, StijnenT, WitJM, de Muinck Keizer- Schrama SM, Drop SL1990 Twenty-four-hour plasma growth hormone (GH) profiles, urinary GH excretion, and plasma insulin-like growth factor-I and -II levels in prepubertal children with chronic renal insufficiency and severe growth retardation. J Clin Endocrinol Metab71:688–695
20. MerriamGR, WachterKW1982 Algorithms for the study of episodic hormone secretion.Am J Physiol243:E310–E318
21. RikkenB, van DoornJ, RingelingA, Van den BrandeJL, MassaG, WitJM1998Plasma levels of insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein-3 in the evaluation of childhood growth hormone deficiency. Horm Res50:166–176
22. BozzolaM, RadettiG, PaganiS, DraghiM, AimarettiG, RondiniG1999The level of bioavailable growth hormone (GH) after the first GH injection predicts the first year’s growth response in GH-deficient children. J Endocrinol Invest22:790–795
23. JorgensenJO, FlyvbjergA, DinesenJ, LundH, AlbertiKG, OrskovH, ChristiansenJS1987Serum profiles and short-term metabolic effect of pituitary and authentic biosynthetic human growth hormone in man. A doubleblind cross-over study. Acta Endocrinol (Copenh)116:381–386
24. HoKY, WeissbergerAJ, StuartMC, DayRO, LazarusL1989The pharmacokinetics, safety and endocrine effects of authentic biosynthetic human growth hormone in normal subjects. Clin Endocrinol (Oxf)30:335–345
25. JacobsenLV, RolanP, ChristensenMS, KnudsenKM, RasmussenMH2000Bioequivalence between ready-to-use recombinant human growth hormone (rhGH) in liquid formulation and rhGH for reconstitution. Growth Horm IGF Res10:93–98
26. BozzolaE, LauriolaS, MessinaMF, BonaG, TinelliC, TatoL2004Effect of different growth hormone dosages on the growth velocity in children born small for gestational age. Horm Res61:98–102
27. van TeunenbroekA, De Muinck Keizer-Schrama SM, Stijnen T, Mouton JW, Blum WF, Mercado M, Baumann G, Drop SL1993 Effect of growth hormone administration frequency on 24-hour growth hormone profiles and levels of other growth related parameters in girls with Turner’s syndrome. Dutch Working Group on Growth Hormone. Clin Endocrinol (Oxf)39:77–84
28. VahlN, MollerN, LauritzenT, ChristiansenJS, JorgensenJO1997Metabolic effects and pharmacokinetics of a growth hormone pulse in healthy adults: relation to age, sex, and body composition. J Clin Endocrinol Metab 82:3612–3618
29. SasT, MulderP, Hokken-KoelegaA2000Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency. J Clin Endocrinol Metab85:3786–3792
30. RoseSR, MunicchiG, BarnesKM, KampGA, UriarteMM, RossJL, CassorlaF, CutlerJrGB1991Spontaneous growth hormone secretion increases during puberty in normal girls and boys. J Clin Endocrinol Metab73:428–435
31. de ZegherF, OngK, van HelvoirtM, MohnA, WoodsK, DungerD2002High-dose growth hormone (GH) treatment in non-GH-deficient children born small for gestational age induces growth responses related to pretreatmentGH secretion and associated with a reversible decrease in insulin sensitivity. J Clin Endocrinol Metab87:148–151
32. ArendsNJ, BoonstraVH, MulderPG, OdinkRJ, Stokvis-BrantsmaWH, Rongen-WesterlakenC, MulderJC, Delemarre-Van de Waal H, Reeser HM, Jansen M, Waelkens JJ, Hokken-Koelega AC 2003GHtreatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial. Clin Endocrinol (Oxf)59:779–787
33. RenehanAG, ZwahlenM, MinderC, O’DwyerST, ShaletSM, Egger M 2004 Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet363:1346–1353
34. Le MarchandL, DonlonT, SeifriedA, KaaksR, RinaldiS, WilkensLR2002Association of a common polymorphism in the human GH1 gene with colorectal neoplasia. J Natl Cancer Inst94:454–460
35. de ZegherF, Hokken-KoelegaA2005Growth hormone therapy for children born small for gestational age: height gain is less dose dependent over the long term than over the short term. Pediatrics115:e458–e462